Cyclacel Pharmaceuticals Inc. (CYCC) Insider Trading Analysis - Executive Transactions & SEC Filings Tracker - Stocknear

Cyclacel Pharmaceuticals ...

NASDAQ: CYCC · Real-Time Price · USD
6.37
-0.40 (-5.91%)
At close: Sep 11, 2025, 3:59 PM

CYCC Insider Trading

We track 431 insider transactions spanning 142 purchases and 74 sales, with a total transaction value of $94.64M. Recent activity shows 11 transactions in the last 90 days, indicating insider distribution among company executives and key stakeholders.

431 Transactions

Name Transaction Date Shares Price Value Type
Kua Khai Loon 10 % Owner
Sep 5, 2025 19,054 $7.01 $133,568.54 S-Sale
Yap Kim Choy 10 % Owner
Sep 4, 2025 186,465 $10.20 $1,901,943 J-Other
Kua Khai Loon 10 % Owner
Sep 4, 2025 186,465 $10.20 $1,901,943 J-Other
Ong Yee Lung 10 % Owner
Sep 4, 2025 186,465 $10.20 $1,901,943 J-Other
Lazar David E. 10 % Owner
Jul 30, 2025 6,750 $12.36 $83,430 S-Sale
Ong Yee Lung 10 % Owner
Jun 20, 2025 218,000 $7.65 $1,667,700
Ong Yee Lung 10 % Owner
Jun 20, 2025 218,000 $9.00 $1,962,000
Ong Yee Lung 10 % Owner
Jun 20, 2025 218,000 $10.20 $2,223,600
Kua Khai Loon 10 % Owner
Jun 20, 2025 218,000 $7.65 $1,667,700
Kua Khai Loon 10 % Owner
Jun 20, 2025 218,000 $9.00 $1,962,000
Kua Khai Loon 10 % Owner
Jun 20, 2025 218,000 $10.20 $2,223,600
Yap Kim Choy 10 % Owner
Jun 20, 2025 218,000 $10.20 $2,223,600
Yap Kim Choy 10 % Owner
Jun 20, 2025 218,000 $7.65 $1,667,700
Yap Kim Choy 10 % Owner
Jun 20, 2025 218,000 $9.00 $1,962,000
Natan David Director
Feb 26, 2025 700,000 $0.33 $231,000 A-Award
Lazar David E. Interim CEO
Feb 26, 2025 194,628,820 $0.03 $5,507,995.606 S-Sale
Ben-tzvi Avraham Director
Feb 26, 2025 700,000 $0.33 $231,000 A-Award
Schwartz Brian Interim Chief Medical Officer
Jan 29, 2024 12,500 $2.28 $28,500 A-Award
Mcbarron Paul See Remarks
Dec 21, 2023 1,886 $3.31 $6,252.09 P-Purchase
Mcbarron Paul See Remarks
Dec 21, 2023 1,886 $3.19 $6,016.34 P-Purchase
Page 1 of 22